Cytokinetics Announces Opening of Third and Final Cohort in ATOMIC-AHF

Cytokinetics Announces Opening of Third and Final Cohort in ATOMIC-AHF

[at noodls] – Independent Data Monitoring Committee Recommends Progression in Ongoing Phase IIb Clinical Trial of Intravenous Form of Omecamtiv Mecarbil in Patients with Acute Heart Failure South San Francisco, CA – … more

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard

Share this post